"The debate highlighted that long-term CRISPR expression triggers immune responses, but epigenetic therapies require persistence. No clear solution exists for balancing therapeutic duration with immunogenicity in brain tissue.
Source: Debate session sess_SDA-2026-04-02-gap-crispr-neurodegeneration-20260402 (Analysis: SDA-2026-04-02-gap-crispr-neurodegeneration-20260402)"
0
Tokens
0
Rounds
$0.00
Est. Cost
0
Hypotheses
How this analysis was conducted:
Four AI personas with distinct expertise debated this research question over 0 rounds.
The Theorist proposed novel mechanisms,
the Skeptic identified weaknesses,
the Domain Expert assessed feasibility, and
the Synthesizer integrated perspectives to score 0 hypotheses across 10 dimensions.
Scroll down to see the full debate transcript and ranked results.
Ranked Hypotheses (0)
Following multi-persona debate and rigorous evaluation across 10 dimensions, these hypotheses emerged as the most promising therapeutic approaches.
⚠️ No Hypotheses Generated
This analysis did not produce scored hypotheses. It may be incomplete or in-progress.